Back
Turtle Beach 10K Form
Sell
40
HEAR
Turtle Beach
Last Price:
15.25
Seasonality Move:
-0.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | HEAR/Turtle Beach Quarterly |
2023-11-07 | 10Q | HEAR/Turtle Beach Quarterly |
2023-08-07 | 10Q | HEAR/Turtle Beach Quarterly |
2023-05-04 | 10Q | HEAR/Turtle Beach Quarterly |
2022-11-14 | 10Q | HEAR/Turtle Beach Quarterly |
2022-08-08 | 10Q | HEAR/Turtle Beach Quarterly |
Receive HEAR News And Ratings
See the #1 stock for the next 7 days that we like better than HEAR
HEAR Financial Statistics
Sales & Book Value
Annual Sales: | $258.12M |
---|---|
Cash Flow: | $-13.88M |
Price / Cash Flow: | 19.79 |
Annual Sales: | $5.07 |
Price / Book: | 3.01 |
Profitability
EPS (TTM): | -0.04000 |
---|---|
Net Income (TTM): | $-2.42M |
Gross Margin: | $75.5M |
Return on Equity: | -2.62% |
Return on Assets: | -1.25% |
Turtle Beach Earnings Forecast
Key Turtle Beach Financial Ratios
- The Gross Profit Margin over the past 16 years for HEAR is 29.25%.
- The Selling, General & Administrative Expenses for HEAR have been equal to 28.98% of Gross Profit Margin.
- The Research & Development expenses have been 6.64% of Revenue.
- The Interest Expense is -2.85% of Operating Income.
- The Net Earning history of HEAR is -6.85% of Total Revenues.
- Per Share Earnings over the last 16 years have been positive in 7 years.
Turtle Beach Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Technology Hardware, Storage & Peripherals |
Sector: | Information Technology |
Current Symbol: | HEAR |
CUSIP: | 900450 |
Website: | turtlebeach.com |
Debt
Debt-to-Equity Ratio: | 0.66 |
---|---|
Current Ratio: | 1.39 |
Quick Ratio: | 0.57 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 9.81 |
HEAR Technical Analysis vs Fundamental Analysis
Sell
40
Turtle Beach (HEAR)
is a Sell
Is Turtle Beach a Buy or a Sell?
-
Turtle Beach stock is rated a Sell
The current Turtle Beach [HEAR] share price is $15.29. The Score for HEAR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.